Des Produits Nestle S.A. Societe's Net Worth
-$2.39 Billion
Who is Des Produits Nestle S.A. Societe?
Des Produits Nestle S.A. Societe does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Prometheus Biosciences, Inc., Axcella Health Inc., and Aimmune Therapeutics, Inc..
SEC CIK
Des Produits Nestle S.A. Societe's CIK is 0001803539
Past Insider Trading and Trends
2020 was Des Produits Nestle S.A. Societe's most active year for acquiring shares with 8 total transactions. Des Produits Nestle S.A. Societe's most active month to acquire stocks was the month of September. 2020 saw Des Produits Nestle S.A. Societe paying a total of $2,384,992,369.00 for 75,138,051 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Prometheus Biosciences, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axcella Health Inc. (AXLA) Snapshot price: $0.6664
InvestorDes Produits Nestle S.A. Societe owns 15,410,979 units of Common Stock which is worth $10,269,876.41. From 2020 to 2022 Des Produits Nestle S.A. Societe acquired a total of 13,042,280 shares in Axcella Health Inc. at a cost of $40,230,489.27.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +49.13% | 3.66M |
$1.64 | $5,999,999.04 | 11.11M |
Oct 13
| |||
Form 4
| +72.96% | 3.14M |
$1.91 | $5,999,999.51 | 7.45M |
Mar 16
| |||
Form 4
|
∞
| 4.31M |
$4.42 | $19,030,491.22 | 4.31M |
Sep 8
| |||
Form 4
| +81.77% | 1.94M |
$4.75 | $9,199,999.50 | 4.31M |
May 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aimmune Therapeutics, Inc. No price found
InvestorDes Produits Nestle S.A. Societe owns 23,408,817 units of Common Stock and 525,634 units of Series A Preferred Stock. In the year 2020 Des Produits Nestle S.A. Societe filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +425.21% | 54.12M |
$34.50 | $1,867,046,401.50 | 66.84M |
Oct 13
| |||
Form 4
| +126.02% | 14.78M |
$132.22 | $489,715,476.78 | 26.51M |
Feb 7 - Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||